-+ 0.00%
-+ 0.00%
-+ 0.00%

80% OF THE EVX-01 VACCINE TARGETS TRIGGER A TUMOR-REACTIVE IMMUNE RESPONSE - EVAXION PRESENTS STRIKING EVX-01 DATA AT THE AACR ANNUAL MEETING

Reuters·04/28/2025 12:00:41

Please log in to view news